Human papillomavirus and lung cancer: an overview and a meta-analysis M. M. TsyganovA. M. PevznerN. V. Litviakov Review – Cancer Research 24 June 2019 Pages: 1919 - 1937
Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis Xueliang ZhouDechao JiaoXinwei Han Review – Cancer Research 01 July 2019 Pages: 1939 - 1948
Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux Clarissa WillersHanna SvitinaChrisna Gouws Review – Cancer Research 10 July 2019 Pages: 1949 - 1976
Genetic profiling as a clinical tool in advanced parathyroid carcinoma Merve KutahyaliogluHa T. NguyenNaifa L. Busaidy Original Article – Cancer Research 15 July 2019 Pages: 1977 - 1986
Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells Somayeh Rahimi BabasheikhaliSoheila RahgozarMahboubeh Mohammadi Original Article – Cancer Research 18 June 2019 Pages: 1987 - 1998
Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone Weiping LiangFuhao WangJian Zhang Original Article – Cancer Research Open access 06 June 2019 Pages: 1999 - 2012
FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions Fernando Cezar-dos-SantosRodolfo Sanches FerreiraKaren Brajão de Oliveira Original Article – Cancer Research 08 June 2019 Pages: 2013 - 2025
A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion Meile MoShun LiuXiaoqiang Qiu Original Article – Cancer Research 26 June 2019 Pages: 2027 - 2038
Aberrant expression of Sec61α in esophageal cancers Kai BachmannMaximillian BockhornKatharina Grupp Original Article – Cancer Research 13 June 2019 Pages: 2039 - 2044
RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition Bryan OronskyCurtis ScribnerPedro Cabrales Original Article – Cancer Research 27 June 2019 Pages: 2045 - 2050
Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes C. ElfgenK. ReeveZ. Varga Original Article – Cancer Research 03 July 2019 Pages: 2051 - 2059
Endocervical adenocarcinoma in situ (AIS) with ovarian and pulmonary involvement: report of a case and review of the literature suggesting a “seed and soil hypothesis” Lars-Christian HornAnne Kathrin HöhnChristine E. Brambs Review – Clinical Oncology 15 July 2019 Pages: 2061 - 2069
Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer Cheol-Kyu ParkJi-Eun KimYoung-Chul Kim Original Article – Clinical Oncology Open access 01 June 2019 Pages: 2071 - 2082
Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer Helena CostaJoel ToumaCecilia Söderberg-Naucler Original Article – Clinical Oncology Open access 15 June 2019 Pages: 2083 - 2095
Does sunitinib have a patient-specific dose without diminishing its antitumor effect on advanced pancreatic neuroendocrine neoplasms? Satoshi MatsuiAtsushi KudoMinoru Tanabe Original Article – Clinical Oncology 30 May 2019 Pages: 2097 - 2104
Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies Mohammed DagherMeritxell SabidóYork Zöllner Original Article – Clinical Oncology Open access 14 June 2019 Pages: 2105 - 2114
A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy Han HanYue ZhaoHaiquan Chen Original Article – Clinical Oncology 07 June 2019 Pages: 2115 - 2122
Kaplan–Meier analysis of salivary gland tumors: prognosis and long-term survival Yair IsraelAdi RachmielRafael Nagler Original Article – Clinical Oncology 11 June 2019 Pages: 2123 - 2130
Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette–Guérin immunotherapy Sung Jin KimDalsan YouJun Hyuk Hong Original Article – Clinical Oncology 21 June 2019 Pages: 2131 - 2140
Cancer patients and music: (prospective) results from a survey to evaluate potential complementary treatment approaches Deniz GencerAlina DielRalf-Dieter Hofheinz Original Article – Clinical Oncology 05 July 2019 Pages: 2141 - 2148
Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial Laura BudauChristian WilhelmAndreas Neubauer Original Article – Clinical Oncology Open access 04 July 2019 Pages: 2149 - 2156
Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer Jun Eul HwangHyeonjong KimIk-Joo Chung Original Article – Clinical Oncology 04 July 2019 Pages: 2157 - 2166
Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series Berardino De BariAlessandra Franzetti-PellandaMahmut Ozsahin Correction 14 June 2019 Pages: 2167 - 2167